Convalescent Plasma for COVID-19 Treatment
Convalescent Plasma as a Possible Treatment for COVID-19
Recruiting
Phase 2
Interventional Study
COVID-19
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- University of Illinois at Chicago · Other
Who this trial is looking for
This trial is looking for patients aged 40 and over who are hospitalized with COVID-19. Participants will receive either convalescent plasma or fresh frozen plasma to see if it helps them recover.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 40 years old or older.
- I am in the hospital due to COVID-19.
- I have tested positive for COVID-19 within the last 72 hours.
- I have symptoms like fever or cough.
- I need extra oxygen to breathe.
- I agree to follow the study instructions.
- I consent to store samples for future tests.
You may not be able to join if
- I have a known Immunoglobulin A deficiency.
- I am on a ventilator.
- I have had a severe transfusion reaction before.
- I have a chronic lung disease requiring oxygen.
- I am pregnant or breastfeeding.
- I received pooled immunoglobulin in the last 30 days.
- I will take another experimental COVID-19 treatment during the study.
- I have severe COVID-19 disease requiring special medications.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Patients who are ill with COVID-19 may benefit from receiving convalescent plasma infusions containing antibodies from donors who have recovered from the disease and are proven to no longer be infected. Given the current public health emergency due to COVID-19, the FDA has recently fast-tracked the use of convalescent plasma. The purpose for this study is to assess if convalescent plasma collected…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients 40 years-old and over who are admitted to the University of Illinois Hospital (UIC) due to COVID-19
* Positive oropharyngeal and/or nasopharyngeal swab test for SARS-CoV-2 by RT-PCR within the preceding 72 hours (performed by University of Illinois Hospital Laboratori…
Contacts
No contact information available.